Pharmesis International Ltd. provided earnings guidance for the six months ended June 30, 2022. For the period, the company expected net loss was mainly due to the control measures such as lockdowns taken by China to contain the spread of the COVID-19 pandemic, which has resulted in a decrease in sales.